DEMENTIA WITH LEWY BODIES

The diagnosis and management of patients with dementia with Lewy bodies (DLB) are challenging. This chapter will (1) review the terms and nomenclature associated with DLB and Lewy body disease (LBD), (2) review which studies are most informative in the diagnostic workup of suspected DLB, (3) review the clinical, neuropsychologic, electrophysiologic, and radiologic features characteristic of DLB, (4) review the spectrum of features and disorders that can precede the development of DLB, (5) review the key management strategies most likely to improve symptomatology in patients with DLB, and (6) discuss some of the controversies and uncertainties in DLB phenomenology.

[1]  M. Folstein,et al.  Mini-Mental State Examination (MMSE) , 2019, Encyclopedia of Gerontology and Population Aging.

[2]  Alan J. Thomas,et al.  Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.

[3]  Alan J. Thomas,et al.  Oxford Textbook of Old Age Psychiatry , 2013 .

[4]  J. Galvin,et al.  Capgras syndrome in Dementia with Lewy Bodies , 2012, International Psychogeriatrics.

[5]  Janna H. Neltner,et al.  GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology , 2012, Neurology.

[6]  E. Mori,et al.  Donepezil for Dementia with Lewy Bodies: A Randomized, Placebo-Controlled Trial , 2012, Annals of neurology.

[7]  K. Meguro,et al.  Improved Visual Hallucination by Donepezil and Occipital Glucose Metabolism in Dementia with Lewy Bodies: The Osaki-Tajiri Project , 2010, European Neurology.

[8]  Roy W Jones,et al.  Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial , 2010, The Lancet Neurology.

[9]  B. Pollock,et al.  Treating Neuropsychiatric Symptoms in Dementia With Lewy Bodies: A Randomized Controlled-trial , 2010, Alzheimer disease and associated disorders.

[10]  B. Boeve.  REM sleep behavior disorder , 2010, Annals of the New York Academy of Sciences.

[11]  J. Dartigues,et al.  A 15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohort , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  C. Rowe,et al.  The 18F-FDG PET Cingulate Island Sign and Comparison to 123I-β-CIT SPECT for Diagnosis of Dementia with Lewy Bodies , 2009, Journal of Nuclear Medicine.

[13]  F. Yasuno,et al.  Depression associated with dementia with Lewy bodies (DLB) and the effect of somatotherapy , 2009, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[14]  G. Stebbins,et al.  Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies , 2008, Movement disorders : official journal of the Movement Disorder Society.

[15]  E. Londos,et al.  Electroencephalogram Variability in Dementia with Lewy Bodies, Alzheimer’s Disease and Controls , 2008, Dementia and Geriatric Cognitive Disorders.

[16]  H. Budka,et al.  Nigral burden of α‐synuclein correlates with striatal dopamine deficit , 2008, Movement disorders : official journal of the Movement Disorder Society.

[17]  F. Manes,et al.  [Neurobiology of consciousness]. , 2008, Vertex.

[18]  R. Armstrong,et al.  Visual signs and symptoms of Parkinson's disease , 2008, Clinical & experimental optometry.

[19]  R. Carpenter,et al.  Diagnostic potential of saccadometry in progressive supranuclear palsy. , 2007, Biomarkers in medicine.

[20]  D. Weintraub,et al.  Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies. , 2007, The American journal of psychiatry.

[21]  A. Lees,et al.  Using the presence of visual hallucinations to differentiate Parkinson’s disease from atypical parkinsonism , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[22]  D. Dickson,et al.  A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. , 2007, Brain : a journal of neurology.

[23]  L. Thal,et al.  Quetiapine for agitation or psychosis in patients with dementia and parkinsonism , 2007, Neurology.

[24]  F. Pasquier,et al.  Efficacy and Safety of Galantamine in Patients with Dementia with Lewy Bodies: A 24-Week Open-Label Study , 2007, Dementia and Geriatric Cognitive Disorders.

[25]  C. Hommet,et al.  Visual recognition memory differentiates dementia with Lewy bodies and Parkinson’s disease dementia , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[26]  T. Montine,et al.  Predicting Lewy Body Pathology in a Community-Based Sample With Clinical Diagnosis of Alzheimer’s Disease , 2006, Journal of geriatric psychiatry and neurology.

[27]  R. McShane,et al.  Effectiveness of acetylcholinesterase inhibitors: diagnosis and severity as predictors of response in routine practice , 2006, International journal of geriatric psychiatry.

[28]  K. Jellinger,et al.  Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? , 2006, Acta Neuropathologica.

[29]  Deborah C Mash,et al.  Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations. , 2006, Parkinsonism & related disorders.

[30]  R. Armstrong.  Plaques and tangles and the pathogenesis of Alzheimer's disease. , 2006, Folia neuropathologica.

[31]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[32]  Enrico Marchioni,et al.  Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[33]  P. Lantos,et al.  Overlap between neurodegenerative disorders , 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.

[34]  U P Mosimann,et al.  Visual perception in Parkinson disease dementia and dementia with Lewy bodies , 2004, Neurology.

[35]  E. Lauterbach.  The neuropsychiatry of Parkinson's disease and related disorders. , 2004, The Psychiatric clinics of North America.

[36]  J. Cummings.  Dementia with Lewy Bodies: Molecular Pathogenesis and Implications for Classification , 2004, Journal of geriatric psychiatry and neurology.

[37]  S. Grill,et al.  Psychiatric comorbidities in patients with Parkinson disease and psychosis , 2004, Neurology.

[38]  G. Ransmayr,et al.  l-Dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia , 2004, Neurology.

[39]  John T. O'Brien,et al.  O1-02-04 Dopamine transporter loss visualised with FP-CIT spect indementia with Lewy bodies , 2004, Neurobiology of Aging.

[40]  A. Baskys.  Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms. , 2004, The Journal of clinical psychiatry.

[41]  A. Destée,et al.  Clozapine in drug induced psychosis in Parkinson’s disease: a randomised, placebo controlled study with open follow up , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[42]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[43]  K. Marder,et al.  Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia , 2004, Movement disorders : official journal of the Movement Disorder Society.

[44]  A. David,et al.  Reality monitoring and visual hallucinations in Parkinson’s disease , 2003, Neuropsychologia.

[45]  E. Bigio,et al.  Can Alzheimer’s Disease and Dementias with Lewy Bodies be Distinguished Clinically? , 2003, Journal of geriatric psychiatry and neurology.

[46]  Donald Grosset,et al.  Role of dopamine transporter imaging in routine clinical practice , 2003, Movement disorders : official journal of the Movement Disorder Society.

[47]  N. Bohnen,et al.  Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. , 2003, Archives of neurology.

[48]  D. Kaufer.  Pharmacologic Treatment Expectations in the Management of Dementia with Lewy Bodies , 2003, Dementia and Geriatric Cognitive Disorders.

[49]  Ronald C Petersen,et al.  Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. , 2003, Mayo Clinic proceedings.

[50]  K. Jellinger.  Age-associated prevalence and risk factors of Lewy body pathology in a general population , 2003, Acta Neuropathologica.

[51]  A. Burns,et al.  Cholinesterase inhibitors for dementia with Lewy bodies. , 2003, Cochrane Database of Systematic Reviews.

[52]  G. E. Smith,et al.  Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism , 2003, Neurology.

[53]  B. Boeve,et al.  Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. , 2003, Sleep medicine.

[54]  K. Jellinger,et al.  Clinical and neuropathological correlates of Lewy body disease , 2003, Acta Neuropathologica.

[55]  R. Sulkava,et al.  Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older , 2003, Journal of neurology, neurosurgery, and psychiatry.

[56]  D. Jeste,et al.  Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies , 2003, Neurology.

[57]  I. McKeith,et al.  SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders , 2003, Movement disorders : official journal of the Movement Disorder Society.

[58]  H. Higuchi,et al.  Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: A case series , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[59]  M. Emre.  Dementia associated with Parkinson's disease , 2003, The Lancet Neurology.

[60]  Y. Agid,et al.  Mental and Behavioral Dysfunction in Movement Disorders , 2003, Humana Press.

[61]  I. McKeith,et al.  Dementia with lewy bodies--diagnosis and treatment. , 2003, Swiss medical weekly.

[62]  A. Murray,et al.  Cardiovascular Effects of Donepezil in Patients with Dementia , 2003, Dementia and Geriatric Cognitive Disorders.

[63]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[64]  Donald E. Schmechel,et al.  Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease , 2003, Acta Neuropathologica.

[65]  W. Hoefnagels,et al.  [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine]. , 2003, Nederlands tijdschrift voor geneeskunde.

[66]  V. Hachinski,et al.  Rates of Cognitive Decline in Alzheimer’s Disease and Dementia with Lewy Bodies , 2003, Dementia and Geriatric Cognitive Disorders.

[67]  P. Tariot,et al.  Use of quetiapine in elderly patients. , 2002, The Journal of clinical psychiatry.

[68]  M. Rossor,et al.  “—but who is that on the other side of you?” Extracampine hallucinations revisited , 2002, The Lancet.

[69]  C G Ballard,et al.  Fluctuations in attention , 2002, Neurology.

[70]  Dennis W Dickson,et al.  Dementia with Lewy Bodies: Neuropathology , 2002, Journal of geriatric psychiatry and neurology.

[71]  D. Perl,et al.  Aggresome‐related biogenesis of Lewy bodies , 2002, The European journal of neuroscience.

[72]  Raymond Scott Turner.  Idiopathic Rapid Eye Movement Sleep Behavior Disorder Is a Harbinger of Dementia with Lewy Bodies , 2002, Journal of geriatric psychiatry and neurology.

[73]  D. Kaufer.  Pharmacologic Therapy of Dementia with Lewy Bodies , 2002, Journal of geriatric psychiatry and neurology.

[74]  K. Kosaka,et al.  Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia. , 2002, Clinical neuropathology.

[75]  A. Singleton,et al.  Clinical and Neuropathological Correlates of Apolipoprotein E Genotype in Dementia with Lewy Bodies , 2002, Dementia and Geriatric Cognitive Disorders.

[76]  R. Petersen,et al.  Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations , 2002, Journal of the International Neuropsychological Society.

[77]  G. Halliday,et al.  Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. , 2002, Brain : a journal of neurology.

[78]  I. Richard,et al.  Parkinson's disease and dementia with Lewy bodies: One disease or two? , 2002, Movement disorders : official journal of the Movement Disorder Society.

[79]  J. Morris,et al.  Familial dementia with Lewy bodies: clinicopathologic analysis of two kindreds. , 2002, Neurology.

[80]  I. McKeith,et al.  Predicting response to rivastigmine in dementia with Lewy Bodies , 2002, European Neuropsychopharmacology.

[81]  K. Heilman,et al.  Relative Frequencies of Alzheimer Disease, Lewy Body, Vascular and Frontotemporal Dementia, and Hippocampal Sclerosis in the State of Florida Brain Bank , 2002, Alzheimer disease and associated disorders.

[82]  Emma J. Burton,et al.  Patterns of Cerebral Atrophy in Dementia with Lewy Bodies Using Voxel-Based Morphometry , 2002, NeuroImage.

[83]  T. Bird,et al.  Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families. , 2002, Archives of neurology.

[84]  E. Perry,et al.  Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex , 2002, Consciousness and Cognition.

[85]  Katharina Buerger,et al.  Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. , 2002, Archives of neurology.

[86]  J. Trojanowski,et al.  Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases , 2002, Annals of neurology.

[87]  Z Walker,et al.  Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand , 2002, Journal of neurology, neurosurgery, and psychiatry.

[88]  B. Michel,et al.  Value of 99mTc-ECD SPET for the diagnosis of dementia with Lewy bodies , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[89]  D. Aarsland,et al.  Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study , 2002, Journal of neurology, neurosurgery, and psychiatry.

[90]  D. Neary,et al.  Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease , 2002, Journal of neurology, neurosurgery, and psychiatry.

[91]  B. Reisberg,et al.  Vascular cognitive impairment , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[92]  Toshiki Nakai,et al.  Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies , 2002, Journal of the Neurological Sciences.

[93]  M. Mahowald,et al.  REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. , 2002, Sleep.

[94]  John T. O'Brien,et al.  A comparison of 99mTc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[95]  B. Boeve,et al.  Current management of sleep disturbances in dementia , 2002, Current neurology and neuroscience reports.

[96]  I. McKeith,et al.  Effects of Rivastigmine on Cognitive Function in Dementia with Lewy Bodies: A Randomised Placebo-Controlled International Study Using the Cognitive Drug Research Computerised Assessment System , 2002, Dementia and Geriatric Cognitive Disorders.

[97]  G. Livingston,et al.  Islington study of dementia subtypes in the community. , 2002, The British journal of psychiatry : the journal of mental science.

[98]  H. Staunton,et al.  Familial diffuse Lewy body disease, eye movement abnormalities, and distribution of pathology. , 2002, Archives of neurology.

[99]  R. Barker,et al.  The heterogeneity of idiopathic Parkinson's disease , 2002, Journal of Neurology.

[100]  J. Cummings,et al.  Efficacy of Olanzapine in the Treatment of Psychosis in Dementia with Lewy Bodies , 2002, Dementia and Geriatric Cognitive Disorders.

[101]  G. Halliday,et al.  Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. , 2002, Brain : a journal of neurology.

[102]  I G McKeith,et al.  Dementia with Lewy bodies: diagnosis and management , 2001, International journal of geriatric psychiatry.

[103]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[104]  I G McKeith,et al.  Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial , 2001, Movement disorders : official journal of the Movement Disorder Society.

[105]  A. Lees,et al.  Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation , 2001 .

[106]  R. Manni,et al.  Hallucinations, REM sleep, and Parkinson’s disease: A medical hypothesis , 2001, Neurology.

[107]  C. Ross,et al.  Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease , 2001, Nature Medicine.

[108]  Makoto Hashimoto,et al.  β-Synuclein Inhibits α-Synuclein Aggregation A Possible Role as an Anti-Parkinsonian Factor , 2001, Neuron.

[109]  W. Poewe,et al.  Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease , 2001, European Journal of Nuclear Medicine.

[110]  Glenda M. Halliday,et al.  Cortical Lewy body pathology in the diagnosis of dementia , 2001, Acta Neuropathologica.

[111]  J. Trojanowski,et al.  Altered expression of the synuclein family mRNA in Lewy body and Alzheimer’s disease , 2001, Brain Research.

[112]  E. Byrne,et al.  Dementia With Lewy Bodies Treated With Rivastigmine: Effects on Cognition, Neuropsychiatric Symptoms, and Sleep , 2001, International Psychogeriatrics.

[113]  Conn Dk.  Cholinesterase inhibitors. Comparing the options for mild-to-moderate dementia. , 2001 .

[114]  Satoshi Minoshima,et al.  Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation , 2001, Annals of neurology.

[115]  D. Galasko.  Lewy bodies and dementia , 2001, Current neurology and neuroscience reports.

[116]  A. Saunders,et al.  Dementia with Lewy bodies and Alzheimer's disease , 2001, Acta Neuropathologica.

[117]  D. Dickson,et al.  Alpha-synuclein and the Lewy body disorders. , 2001, Current opinion in neurology.

[118]  Ian G. McKeith,et al.  Comparison of Extrapyramidal Signs in Dementia With Lewy Bodies and Parkinson's Disease , 2001 .

[119]  B. Boeve,et al.  Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy , 2001, Movement disorders : official journal of the Movement Disorder Society.

[120]  E. Peskind,et al.  Increased alpha 2-adrenergic receptor binding in locus coeruleus projection areas in dementia with Lewy bodies , 2001, Neurobiology of Aging.

[121]  R Bucks,et al.  Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. , 2001, Archives of neurology.

[122]  Z Walker,et al.  Long-Term Use of Rivastigmine in Patients With Dementia With Lewy Bodies: An Open-Label Trial , 2001, International Psychogeriatrics.

[123]  M N Rossor,et al.  Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia , 2001, Neurology.

[124]  B. Miller,et al.  CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .

[125]  I. McKeith,et al.  The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease , 2001, International journal of geriatric psychiatry.

[126]  I. McKeith,et al.  A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia , 2001, International journal of geriatric psychiatry.

[127]  R. Elble,et al.  Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[128]  J D Fenwick,et al.  Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD , 2001, Neurology.

[129]  K. Ishii,et al.  Occipital Glucose Metabolism in Dementia with Lewy Bodies with and without Parkinsonism: A Study Using Positron Emission Tomography , 2001, Dementia and Geriatric Cognitive Disorders.

[130]  I. McKeith,et al.  A Comparison of Medial and Lateral Temporal Lobe Atrophy in Dementia with Lewy Bodies and Alzheimer’s Disease: Magnetic Resonance Imaging Volumetric Study , 2001, Dementia and Geriatric Cognitive Disorders.

[131]  P. Lantos,et al.  Dementia with Lewy bodies studied with positron emission tomography. , 2001, Archives of neurology.

[132]  K. Blennow,et al.  Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. , 2001, Archives of neurology.

[133]  R. van Reekum,et al.  Dementia with Lewy bodies in Down's syndrome , 2001, International journal of geriatric psychiatry.

[134]  L. Boylan,et al.  Developmental apraxia arising from neonatal brachial plexus palsy , 2001, Neurology.

[135]  J Q Trojanowski,et al.  Synucleinopathies: clinical and pathological implications. , 2001, Archives of neurology.

[136]  J. Hodges,et al.  Semantic memory is impaired in both dementia with Lewy bodies and dementia of Alzheimer's type: a comparative neuropsychological study and literature review , 2001, Journal of neurology, neurosurgery, and psychiatry.

[137]  Ian G. McKeith,et al.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.

[138]  Murat Emre,et al.  Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study , 2000, The Lancet.

[139]  Raymond Scott Turner,et al.  The pathology of REM sleep behavior disorder with comorbid Lewy body dementia. , 2000, Neurology.

[140]  P. O'Suilleabhain,et al.  Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease , 2000, Neurology.

[141]  I. McKeith,et al.  Clinical Lewy Body Syndromes , 2000, Annals of the New York Academy of Sciences.

[142]  E. Perry,et al.  Delusions associated with elevated muscarinic binding in dementia with Lewy bodies , 2000, Annals of neurology.

[143]  B. Sommer,et al.  Mouse models of α-synucleinopathy and Lewy pathology , 2000, Experimental Gerontology.

[144]  J. Trojanowski,et al.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. , 2000, Science.

[145]  I. McKeith,et al.  Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. , 2000, Neurologic clinics.

[146]  I. McKeith,et al.  Dementia with Lewy bodies: findings from an international multicentre study , 2000, International journal of geriatric psychiatry.

[147]  K. Wesnes,et al.  Quantification and Characterisation of Fluctuating Cognition in Dementia with Lewy Bodies and Alzheimer’s Disease , 2000, Dementia and Geriatric Cognitive Disorders.

[148]  E. Mori.  [Dementia with Lewy bodies]. , 2000, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[149]  I G McKeith,et al.  MRI volumetric correlates of white matter lesions in dementia with lewy bodies and Alzheimer's disease , 2000, International journal of geriatric psychiatry.

[150]  I. Richard,et al.  Worsening of motor function in Parkinson's disease: a "typical" response to "atypical" antipsychotic medications. , 2000, Neurology.

[151]  S. Leurgans,et al.  Olanzapine and clozapine , 2000, Neurology.

[152]  A. Schrag,et al.  Low-dose olanzapine for levodopa induced dyskinesias , 2000, Neurology.

[153]  J. Ringman,et al.  Treatment of REM sleep behavior disorder with donepezil: A report of three cases , 2000, Neurology.

[154]  Douglas Galasko,et al.  Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study , 2000, International journal of geriatric psychiatry.

[155]  I G McKeith,et al.  The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. , 2000, The British journal of psychiatry : the journal of mental science.

[156]  C. Jack,et al.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.

[157]  J. Gilbert,et al.  Lewy body and Alzheimer pathology in a family with the amyloid-β precursor protein APP717 gene mutation , 2000, Acta Neuropathologica.

[158]  Y. Agid,et al.  Hallucinations, REM sleep, and Parkinson’s disease , 2000, Neurology.

[159]  R. Hamilton,et al.  Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry , 2000, Brain pathology.

[160]  A. Swann,et al.  One Year Follow-Up of Parkinsonism in Dementia with Lewy Bodies , 2000, Dementia and Geriatric Cognitive Disorders.

[161]  E. Perry,et al.  Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease and in relation to neuroleptic medication , 2000, Neuroscience.

[162]  S. Wisniewski,et al.  Predictors of progression in patients with AD and Lewy bodies , 2000, Neurology.

[163]  H. Yamanouchi,et al.  Access www.neurology.org now for full-text articles , 2001, Neurology.

[164]  S. Wisniewski,et al.  Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies , 2000, Neurology.

[165]  E. Perry,et al.  Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial , 2000, International journal of geriatric psychiatry.

[166]  J. Trojanowski,et al.  Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons , 2000, The Journal of Neuroscience.

[167]  I G McKeith,et al.  Quantifying fluctuation in dementia with Lewy bodies, Alzheimer’s disease, and vascular dementia , 2000, Neurology.

[168]  J. Yesavage,et al.  Combined assessment of tau and neuronal thread protein in Alzheimer’s disease CSF , 2000, Neurology.

[169]  B. Hyman,et al.  α-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining , 2000, Acta Neuropathologica.

[170]  Nobuyuki Okamura,et al.  Glucose Hypometabolism and Neuropathological Correlates in Brains of Dementia with Lewy Bodies , 2000, Experimental Neurology.

[171]  N. Herrmann,et al.  Donepezil for behavioural disorders associated with Lewy bodies: a case series , 2000, International journal of geriatric psychiatry.

[172]  E. Mori,et al.  Visuoperceptual impairment in dementia with Lewy bodies. , 2000, Archives of neurology.

[173]  I G McKeith,et al.  MRI volumetric study of dementia with Lewy bodies , 2000, Neurology.

[174]  A. Swann,et al.  Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies , 2000, Neurology.

[175]  R. Howard,et al.  Donepezil for the treatment of psychosis in dementia with Lewy bodies , 2000, International journal of geriatric psychiatry.

[176]  C. Katona,et al.  Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies , 2000, International journal of geriatric psychiatry.

[177]  L. Thal,et al.  Diagnostic accuracy of dementia with Lewy bodies. , 2000, Archives of neurology.

[178]  N. Leopold.  Risperidone treatment of drug‐related psychosis in patients with parkinsonism , 2000, Movement disorders : official journal of the Movement Disorder Society.

[179]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[180]  B. Boeve,et al.  Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. , 2000, Brain : a journal of neurology.

[181]  P. Barber,et al.  The electroencephalogram in dementia with Lewy bodies , 2000, Acta neurologica Scandinavica.

[182]  I. McKeith,et al.  Dementia with Lewy bodies , 1999, Neurology.

[183]  R. Lipton,et al.  Validity of clinical criteria for the diagnosis of dementia with Lewy bodies , 1999, Neurology.

[184]  Masanori Kato,et al.  Clinicopathological multiplicity of dementia with Lewy bodies , 1999 .

[185]  J. Hobson.  Dreaming as Delirium: How the Brain Goes Out of Its Mind , 1999 .

[186]  J Q Trojanowski,et al.  Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[187]  J. Growdon,et al.  Clinical and quantitative pathologic correlates of dementia with Lewy bodies , 1999, Neurology.

[188]  C. Ballard,et al.  Neuropsychiatric aspects of alzheimer’s disease , 1999, Current psychiatry reports.

[189]  I Litvan,et al.  Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias , 1999, Neurology.

[190]  I G McKeith,et al.  Report of the second dementia with Lewy body international workshop , 1999, Neurology.

[191]  D. Galasko.  A CLINICAL APPROACH TO DEMENTIA WITH LEWY BODIES , 1999 .

[192]  M. Kokai,et al.  Familial dementia with Lewy bodies (DLB). , 1999, Clinical neuropathology.

[193]  B. Lawlor,et al.  A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia , 1999, Neurology.

[194]  C. Katona,et al.  In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies , 1999, The Lancet.

[195]  I G McKeith,et al.  Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. , 1999, Brain : a journal of neurology.

[196]  K. Kameyama,et al.  Alterations of muscarinic acetylcholine receptor subtypes in diffuse Lewy body disease: relation to Alzheimer’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[197]  D. Aarsland,et al.  Olanzapine for psychosis in patients with Parkinson's disease with and without dementia. , 1999, The Journal of neuropsychiatry and clinical neurosciences.

[198]  J. O’Brien,et al.  Treating behavioural and psychological signs in Alzheimer's disease , 1999, BMJ.

[199]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging , 1999, Journal of neurology, neurosurgery, and psychiatry.

[200]  K. Ishii,et al.  Regional cerebral blood flow difference between dementia with Lewy bodies and AD , 1999, Neurology.

[201]  D. Dickson,et al.  Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy‐verified sample , 1999, International journal of geriatric psychiatry.

[202]  E. Perry,et al.  Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. , 1999, The American journal of psychiatry.

[203]  I. McKeith,et al.  Olanzapine in dementia with Lewy bodies: a clinical study , 1999, International journal of geriatric psychiatry.

[204]  E. Perry,et al.  Acetylcholine in mind: a neurotransmitter correlate of consciousness? , 1999, Trends in Neurosciences.

[205]  E. Mori,et al.  Clinical Diagnosis of Dementia with Lewy Bodies in a Japanese Dementia Registry , 1999, Dementia and Geriatric Cognitive Disorders.

[206]  J. Friedman,et al.  Quetiapine for the treatment of drug‐induced psychosis in Parkinson's disease , 1999 .

[207]  A. Lang,et al.  Diffuse Lewy Body Disease Presenting as Multiple System Atrophy , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[208]  I G McKeith,et al.  Medial temporal lobe atrophy on MRI in dementia with Lewy bodies , 1999, Neurology.

[209]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[210]  I G McKeith,et al.  EEG findings in dementia with Lewy bodies and Alzheimer’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[211]  J. Trojanowski,et al.  Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease , 1999, Annals of neurology.

[212]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[213]  D. Jeste,et al.  Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. , 1999, The Journal of clinical psychiatry.

[214]  I. McKeith,et al.  The Prevalence, Assessment and Associations of Falls in Dementia with Lewy Bodies and Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.

[215]  I. McKeith,et al.  Simple Standardised NeuropsychologicalAssessments Aid in the Differential Diagnosis of Dementia with Lewy Bodies from Alzheimer’s Disease and Vascular Dementia , 1999, Dementia and Geriatric Cognitive Disorders.

[216]  P. Lantos,et al.  Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies , 1999, British Journal of Psychiatry.

[217]  I G McKeith,et al.  Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study , 1999, Psychological Medicine.

[218]  D. Aarsland,et al.  Donepezil for dementia with Lewy bodies: a case study , 1999, International journal of geriatric psychiatry.

[219]  I. McKeith,et al.  High prevalence of neurovascular instability in neurodegenerative dementias , 1998, Neurology.

[220]  E. Jaros,et al.  Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases. , 1998, Neuroreport.

[221]  J. Langston,et al.  Novel α-Synuclein-Immunoreactive Proteins in Brain Samples from the Contursi Kindred, Parkinson's, and Alzheimer's Disease , 1998, Experimental Neurology.

[222]  O. Lopez,et al.  Dementia with Lewy bodies , 1998, Neurology.

[223]  J Q Trojanowski,et al.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. , 1998, The American journal of pathology.

[224]  E. Perry,et al.  Nigrostriatal dopaminergic activities in dementia with lewy bodies in relation to neuroleptic sensitivity: comparisons with parkinson’s disease , 1998, Biological Psychiatry.

[225]  K. Rockwood,et al.  Donepezil for Treatment of Dementia With Lewy Bodies: A Case Series of Nine Patients , 1998, International Psychogeriatrics.

[226]  A. Takeda,et al.  BRIEF COMMUNICATION Mutation in the α-Synuclein Gene and Sporadic Parkinson's Disease, Alzheimer's Disease, and Dementia with Lewy Bodies , 1998, Experimental Neurology.

[227]  I. McKeith,et al.  A Prospective Study of Dementia with Lewy Bodies — Clinical Data , 1998, European Psychiatry.

[228]  J. Langston,et al.  The native form of α-synuclein is not found in the cerebrospinal fluid of patients with Parkinson's disease or normal controls , 1998, Neuroscience Letters.

[229]  F. Pasquier,et al.  Tacrine efficacy in Lewy body dementia , 1998, International journal of geriatric psychiatry.

[230]  E. Mori,et al.  Medial temporal and whole-brain atrophy in dementia with Lewy bodies , 1998, Neurology.

[231]  R. Schiffer,et al.  A review of Lewy body disease, an emerging concept of cortical dementia. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[232]  Nigel J. Cairns,et al.  Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.

[233]  K. Jellinger,et al.  Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. , 1998, Archives of neurology.

[234]  K. Ishii,et al.  Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease , 1998, Neurology.

[235]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[236]  W. Burke,et al.  Neuroleptic sensitivity to clozapine in dementia with Lewy bodies. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[237]  J. Grace,et al.  Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease , 1998, The Lancet.

[238]  J Q Trojanowski,et al.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.

[239]  B. Hyman,et al.  Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity , 1998, Journal of neuropathology and experimental neurology.

[240]  P. Lantos,et al.  The Spatial Patterns of Lewy Bodies, Senile Plaques, and Neurofibrillary Tangles in Dementia with Lewy Bodies , 1998, Experimental Neurology.

[241]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[242]  R. Johnson,et al.  The medial temporal lobe in dementia with lewy bodies: A comparative study with Alzheimer's disease , 1998, Annals of neurology.

[243]  H. Soininen,et al.  The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease , 1997, Neuroreport.

[244]  P. Ince,et al.  The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies , 1997, Acta neurologica Scandinavica.

[245]  J T O'Brien,et al.  Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment , 1997, Psychological Medicine.

[246]  A. Myers,et al.  Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with parkinson's, alzheimer's with parkinsonism, and alzheimer's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.

[247]  Hiroaki Kazui,et al.  Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography , 1997, Neuroscience Letters.

[248]  Z. Wszolek,et al.  Familial parkinsonism, dementia, and lewy body disease: Study of family G , 1997, Annals of neurology.

[249]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[250]  Raymond Scott Turner,et al.  Probable diffuse Lewy body disease presenting as REM sleep behavior disorder , 1997, Neurology.

[251]  E. Mori,et al.  Procedural memory in patients with mild Alzheimer's disease. , 1997, Dementia and geriatric cognitive disorders.

[252]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[253]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[254]  C. Katona,et al.  Dementia with Lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon mission tomography , 1997, European Journal of Nuclear Medicine.

[255]  C. Hofstetter,et al.  Dementia with Lewy Bodies Versus Pure Alzheimer Disease: Differences in Cognition, Neuropathology, Cholinergic Dysfunction, and Synapse Density , 1997, Journal of neuropathology and experimental neurology.

[256]  G. Frisoni,et al.  Drug treatment in Lewy body dementia. , 1997, Dementia and geriatric cognitive disorders.

[257]  J. Delacour.  Neurobiology of consciousness: an overview , 1997, Behavioural Brain Research.

[258]  B. Berninger,et al.  Neurotrophins and activity-dependent plasticity of cortical interneurons , 1997, Trends in Neurosciences.

[259]  W. R. Lieb,et al.  Differential Sensitivities of Mammalian Neuronal and Muscle Nicotinic Acetylcholine Receptors to General Anesthetics , 1997, Anesthesiology.

[260]  P. Flood,et al.  Alpha4beta2 Neuronal Nicotinic Acetylcholine Receptors in the Central Nervous System Are Inhibited by Isoflurane and Propofol, but alpha7‐type Nicotinic Acetylcholine Receptors Are Unaffected , 1997, Anesthesiology.

[261]  Gerhard Ransmayr,et al.  Brain perfusion scintigraphy with99mTc-HMPAO or99mTc-ECD and123I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease , 1997, European Journal of Nuclear Medicine.

[262]  J. O'Brien,et al.  A Prospective Study of Psychotic Symptoms in Dementia Sufferers: Psychosis in Dementia , 1997, International Psychogeriatrics.

[263]  M. Sambrook,et al.  Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[264]  F. Bylsma,et al.  Lewy bodies and progressive dementia: A critical review and meta-analysis , 1997, Journal of the International Neuropsychological Society.

[265]  Gary L. Wenk,et al.  The Nucleus Basalis Magnocellularis Cholinergic System: One Hundred Years of Progress , 1997, Neurobiology of Learning and Memory.

[266]  Z Walker,et al.  Neuropsychological performance in Lewy body dementia and Alzheimer's disease , 1997, British Journal of Psychiatry.

[267]  S. Fahn,et al.  Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse lewy body disease and 34 pathologically confirmed cases of parkinson's disease , 1997, Neurology.

[268]  M. Sarter,et al.  Cognitive functions of cortical acetylcholine: toward a unifying hypothesis , 1997, Brain Research Reviews.

[269]  T. Ala,et al.  Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[270]  L. Hansen,et al.  Criteria for Alzheimer's Disease and the Nosology of Dementia with Lewy Bodies , 1997, Neurology.

[271]  D. Benson,et al.  Dementia with Lewy bodies , 1996, Neurology.

[272]  B. Postle,et al.  Intact implicit memory for novel patterns in Alzheimer's disease. , 1996, Learning & memory (Cold Spring Harbor, N.Y.).

[273]  R. Schiffer,et al.  Psychiatric features in diffuse Lewy body disease , 1996, Neurology.

[274]  J. Cummings,et al.  Neuropsychiatric aspects of Alzheimer's disease , 1996, Neurology.

[275]  L. Honig,et al.  Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. , 1996, The American journal of psychiatry.

[276]  Litvan,et al.  Neuropsychiatric Syndromes in Neurodegenerative Disease: Frequency and Signficance. , 1996, Seminars in clinical neuropsychiatry.

[277]  M. Hutchinson,et al.  Cholinesterase inhibition in Parkinson's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[278]  S. Minoshima,et al.  In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease , 1996, Annals of neurology.

[279]  R. Albin,et al.  Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease , 1996, Neurology.

[280]  Nick C Fox,et al.  Visualisation and quantification of rates of atrophy in Alzheimer's disease , 1996, The Lancet.

[281]  Douglas Galasko,et al.  Neuropsychological Deficits Associated with Diffuse Lewy Body Disease , 1996, Brain and Cognition.

[282]  D. Salmon,et al.  Clinical and Neuropathological Findings in Lewy Body Dementias , 1996, Brain and Cognition.

[283]  C. Ballard,et al.  Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type. , 1996, Age and ageing.

[284]  G. Halliday,et al.  Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[285]  M. Memo,et al.  Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease? , 1996, Trends in pharmacological sciences.

[286]  Kenneth Hugdahl,et al.  Cognitive influences on human autonomic nervous system function , 1996, Current Opinion in Neurobiology.

[287]  V Hachinski,et al.  Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease , 1996, Neurology.

[288]  A. Goate,et al.  Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease , 1996, The Lancet.

[289]  D. Galasko,et al.  Neocortical Lewy Body Counts Correlate with Dementia in the Lewy Body Variant of Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.

[290]  K. Kosaka.  Diffuse Lewy body disease. , 1995, Internal medicine.

[291]  I. McKeith,et al.  Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[292]  J. Friedman,et al.  Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes. , 1995, The Journal of clinical psychiatry.

[293]  I. Mena,et al.  SPECT in Dementia: Clinical and Pathological Correlation , 1995, Journal of the American Geriatrics Society.

[294]  I. McKeith,et al.  Senile dementia of lewy body type—a review of clinical and pathological features: Implications for treatment , 1995 .

[295]  I. McKeith,et al.  Neuroleptic sensitivity to risperidone in Lewy body dementia , 1995, The Lancet.

[296]  Denis Paré,et al.  Conscious and pre-conscious processes as seen from the standpoint of sleep-waking cycle neurophysiology , 1995, Neuropsychologia.

[297]  M. Esiri,et al.  Prospective study of relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer's disease. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[298]  M. Ilyas Kamboh,et al.  A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism , 1995, Nature Genetics.

[299]  E. Perry,et al.  Acetylcholine and Hallucinations - Disease-Related Compared to Drug-Induced Alterations in Human Consciousness , 1995, Brain and Cognition.

[300]  R. Martins,et al.  ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome , 1995, Neuroreport.

[301]  P. D'Ath,et al.  Risperidone for psychotic and behavioural symptoms in Lewy body dementia , 1995, The Lancet.

[302]  D. Pollen,et al.  Familial Alzheimer's disease and cortical Lewy bodies: is there a genetic susceptibility factor? , 1995, Dementia.

[303]  J. Newman.  Thalmic Contributions to Attention and Consciousness , 1995, Consciousness and Cognition.

[304]  G. Wilcock,et al.  The prevalence and phenomenology of psychotic symptoms in dementia sufferers , 1995 .

[305]  Margaret E. Knapp,et al.  Consciousness: A neurobiological approach , 1995, Integrative physiological and behavioral science : the official journal of the Pavlovian Society.

[306]  J. Bogen,et al.  On the Neurophysiology of Consciousness: 1. An Overview , 1995, Consciousness and Cognition.

[307]  T. Wisniewski,et al.  Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. , 1995, The Biochemical journal.

[308]  S. Fahn,et al.  Parkinsonian features of eight pathologically diagnosed cases of diffuse lewy body disease , 1995, Movement disorders : official journal of the Movement Disorder Society.

[309]  D. Hannequin,et al.  Clozapine in Parkinson's disease , 1995, The Lancet.

[310]  G. Schellenberg,et al.  Apolipoprotein E genotypes in Parkinson's disease with and without dementia , 1995, Annals of neurology.

[311]  I. McKeith,et al.  Do differences in visuospatial ability between senile dementias of the Alzheimer and Lewy body types reflect differences solely in mnemonic function? , 1995, Journal of clinical and experimental neuropsychology.

[312]  D. Irving,et al.  Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology , 1995, Neuroscience.

[313]  L. Thal,et al.  The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease , 1995, Annals of neurology.

[314]  E. Perry,et al.  Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. , 1994, The American journal of pathology.

[315]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[316]  S. Shergill,et al.  What is the clinical prevalence of lewy body dementia? , 1994 .

[317]  L. R. Hill,et al.  The apolipoprotein E allele epsi;4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease , 1994, Neurology.

[318]  L A Hansen,et al.  Clinical-neuropathological correlations in Alzheimer's disease and related dementias. , 1994, Archives of neurology.

[319]  I. McKeith,et al.  The Clinical Diagnosis and Misdiagnosis of Senile Dementia of Lewy Body Type (SDLT) , 1994, British Journal of Psychiatry.

[320]  E. Perry,et al.  Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. , 1994, Dementia.

[321]  G. Wilcock,et al.  Tacrine for senile dementia of Alzheimer's or Lewy body type , 1994, The Lancet.

[322]  R. Levy,et al.  Neuropathological Correlates of Psychotic Phenomena in Confirmed Alzheimer's Disease , 1994, British Journal of Psychiatry.

[323]  G. Hesslow,et al.  Will neuroscience explain consciousness? , 1994, Journal of theoretical biology.

[324]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[325]  I. Ferrier,et al.  An evaluation of the predictive validity and inter‐rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type , 1994, Neurology.

[326]  R. Lévy,et al.  Charles bonnet syndrome plus: Complex visual hallucinations of charles bonnet syndrome type in late paraphrenia , 1994 .

[327]  B. Lawlor,et al.  The use of risperidone, an atypical neuroleptic, in lewy body disease , 1994 .

[328]  Ronald A. Cohen,et al.  Habituation and sensitization of the orienting response following bilateral anterior cingulotomy , 1994, Neuropsychologia.

[329]  K. Davis,et al.  Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. , 1994, Neuroreport.

[330]  Mrinalini Honavar,et al.  Lewy bodies and response to tacrine in Alzheimer's disease , 1994, The Lancet.

[331]  C. Lippa,et al.  Alzheimer's disease and Lewy body disease: A comparative clinicopathological study , 1994, Annals of neurology.

[332]  B. Baars,et al.  A Neural Attentional Model for Access to Consciousness: A Global Workspace Perspective , 1993 .

[333]  J. Degos,et al.  Severe frontal syndrome associated with infarcts of the left anterior cingulate gyrus and the head of the right caudate nucleus. A clinico-pathological case. , 1993, Brain : a journal of neurology.

[334]  E. Masliah,et al.  Plaque‐Only Alzheimer Disease is Usually the Lewy Body Variant, and Vice Versa , 1993, Journal of neuropathology and experimental neurology.

[335]  J. Kurth,et al.  Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease. , 1993, American journal of medical genetics.

[336]  D. Galasko,et al.  Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies , 1993, Neurology.

[337]  S. W. Williams,et al.  The treatment of diffuse lewy body disease: A pilot study , 1993 .

[338]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[339]  Michael Alford,et al.  Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies , 1993, Brain Research.

[340]  R. N. Mohan,et al.  Idiopathic clouding of consciousness—do the patients have cortical lewy body disease? , 1993 .

[341]  D. Dickson,et al.  Pathology and Biology of the Lewy Body , 1993, Journal of neuropathology and experimental neurology.

[342]  D. G. Gorman,et al.  Physostigmine ameliorates the delusions of Alzheimer's disease , 1993, Biological Psychiatry.

[343]  R. Levy,et al.  The Lewy-Body Variant of Alzheimer's Disease , 1993, British Journal of Psychiatry.

[344]  B. Sahakian,et al.  A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[345]  M M Mesulam,et al.  Cholinergic innervation of the human thalamus: Dual origin and differential nuclear distribution , 1992, The Journal of comparative neurology.

[346]  R. Lipton,et al.  Amyloid angiopathy in diffuse Lewy body disease , 1992, Neurology.

[347]  E. Perry,et al.  Operational criteria for senile dementia of Lewy body type (SDLT) , 1992, Psychological Medicine.

[348]  Lennox Gg.  Lewy body dementia. , 1992 .

[349]  E. Perry,et al.  Neuroleptic sensitivity in patients with senile dementia of Lewy body type. , 1992, BMJ.

[350]  J. Idle,et al.  Mutant debrisoquine hydroxylation genes in Parkinson's disease , 1992, The Lancet.

[351]  C. Jack,et al.  MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.

[352]  B. E. Jones,et al.  Paradoxical sleep and its chemical/structural substrates in the brain , 1991, Neuroscience.

[353]  Nancy J. Woolf,et al.  Cholinergic systems in mammalian brain and spinal cord , 1991, Progress in Neurobiology.

[354]  R. Godwin-Austen,et al.  Dementia associated with cortical Lewy bodies : proposed clinical diagnostic criteria , 1991 .

[355]  P. Ince,et al.  Topography, Extent, and Clinical Relevance of Neurochemical Deficits in Dementia of Lewy Body Type, Parkinson's Disease, and Alzheimer's Disease , 1991, Annals of the New York Academy of Sciences.

[356]  P. Ince,et al.  Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients , 1991, Journal of the Neurological Sciences.

[357]  I. Ferrier,et al.  Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases , 1991, Journal of the Neurological Sciences.

[358]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[359]  D. Dickson,et al.  Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease , 1991, Neurology.

[360]  D. Salmon,et al.  Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer's disease , 1991, Neurology.

[361]  A. N. Exton-smith,et al.  Further evidence of preserved memory function in Alzheimer's disease , 1991 .

[362]  J. Cummings.  Behavioral Complications of Drug Treatment of Parkinson's Disease , 1991, Journal of the American Geriatrics Society.

[363]  E. Tangalos,et al.  The short test of mental status. Correlations with standardized psychometric testing. , 1991, Archives of neurology.

[364]  J. Moossy,et al.  Neuropathologic and neurochemical correlates of psychosis in primary dementia. , 1991, Archives of neurology.

[365]  D. Paré,et al.  Fast oscillations (20-40 Hz) in thalamocortical systems and their potentiation by mesopontine cholinergic nuclei in the cat. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[366]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[367]  E. Perry,et al.  Evidence of a Monoaminergic‐Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body Dementia , 1990, Journal of neurochemistry.

[368]  J. Jankovic,et al.  Variable expression of Parkinson's disease , 1990, Neurology.

[369]  L. Wolfson,et al.  Antemortem diagnosis of diffuse Lewy body disease , 1990, Neurology.

[370]  D. Dickson.  Lewy body variant , 1990, Neurology.

[371]  A. Burns,et al.  Psychiatric Phenomena in Alzheimer's Disease. I: Disorders of Thought Content , 1990, British Journal of Psychiatry.

[372]  K. Kosaka,et al.  Diffuse lewy body disease in Japan , 1990, Journal of Neurology.

[373]  R. Miettinen,et al.  Effects of quisqualic acid nucleus basalis lesioning on cortical EEG, passive avoidance and water maze performance , 1990, Brain Research Bulletin.

[374]  L. Schneider,et al.  A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia , 1990, Journal of the American Geriatrics Society.

[375]  J. Danby,et al.  General practice obstetrics in Bradford , 1990, BMJ.

[376]  R. Lévy.  Tacrine and lecithin in Alzheimer's disease , 1990 .

[377]  M. Mendez,et al.  Disorders of the visual system in Alzheimer's disease. , 1990, Journal of clinical neuro-ophthalmology.

[378]  P. J. Whitehouse,et al.  Complex visual disturbances in Alzheimer's disease , 1990, Neurology.

[379]  Z. J. Lipowski.  Delirium (acute confusional states). , 1990, JAMA.

[380]  M. Steriade,et al.  Brainstem Control of Wakefulness and Sleep , 1990, Springer US.

[381]  Robert H. Perry,et al.  Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.

[382]  L. Thal,et al.  The Lewy body variant of Alzheimer's disease , 1990, Neurology.

[383]  R. Godwin-Austen,et al.  Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[384]  R. Godwin-Austen,et al.  Diffuse Lewy body disease: clinical features in 15 cases. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[385]  P. Lantos,et al.  Cortical Lewy body dementia: clinical features and classification. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[386]  D H Barer,et al.  The natural history and functional consequences of dysphagia after hemispheric stroke. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[387]  E. Perry,et al.  CLINICALLY AND NEUROPATHOLOGICALLY DISTINCT FORM OF DEMENTIA IN THE ELDERLY , 1989, The Lancet.

[388]  H. Wiśniewski,et al.  An Antigenic Profile of Lewy Bodies: Immunocytochemical Indication for Protein Phosphorylation and Ubiquitination , 1989, Journal of neuropathology and experimental neurology.

[389]  M. Dam,et al.  [99mTc]-HM-PAO SPECT in Parkinson's Disease , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[390]  S. Kuzuhara,et al.  [Clinical features of diffuse Lewy body disease. Report of 8 cases and review of the literature]. , 1988, Rinsho shinkeigaku = Clinical neurology.

[391]  T. Imai,et al.  A Case of Diffuse Lewy Body and Alzheimer's Diseases with Periodic Synchronous Discharges , 1988, Journal of neuropathology and experimental neurology.

[392]  Barbara E. Jones,et al.  Neurotoxic lesions of the dorsolateral pontomesencephalic tegmentum-cholinergic cell area in the cat. II. Effects upon sleep-waking states , 1988, Brain Research.

[393]  R. Llinás,et al.  The functional states of the thalamus and the associated neuronal interplay. , 1988, Physiological reviews.

[394]  B. Jones,et al.  Neurotoxic lesions of the dorsolateral pontomesencephalic tegmentum-cholinergic cell area in the cat. I. Effects upon the cholinergic innervation of the brain , 1988, Brain Research.

[395]  D. Nebert,et al.  Characterization of the common genetic defect in humans deficient in debrisoquine metabolism , 1988, Nature.

[396]  W. Gibb,et al.  Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). , 1987, Brain : a journal of neurology.

[397]  D. Neary,et al.  Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[398]  M. Borchert,et al.  Assessment of visual impairment in patients with Alzheimer's disease. , 1987, American journal of ophthalmology.

[399]  S. Mirra,et al.  Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients , 1987, Neurology.

[400]  J. A. Hobson,et al.  Evolving concepts of sleep cycle generation: From brain centers to neuronal populations , 1986, Behavioral and Brain Sciences.

[401]  S. M. Sumi,et al.  Parkinson's disease in patients with Alzheimer's disease. , 1986, Archives of neurology.

[402]  K Kosaka,et al.  Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? , 1984, Clinical neuropathology.

[403]  Kenji Kosaka,et al.  Lewy bodies in cerebral cortex. Report of three cases , 1978, Acta Neuropathologica.

[404]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[405]  J A Hobson,et al.  Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. , 1975, Science.

[406]  H H Jasper,et al.  Acetylcholine Liberation from Cerebral Cortex during Paradoxical (REM) Sleep , 1971, Science.

[407]  A. Karczmar,et al.  A pharmacological model of paradoxical sleep: the role of cholinergic and monoamine systems. , 1970, Physiology & behavior.

[408]  L. Forno,et al.  CONCENTRIC HYALIN INTRANEURONAL INCLUSIONS OF LEWY TYPE IN THE BRAINS OF ELDERLY PERSONS (50 INCIDENTAL CASES): RELATIONSHIP TO PARKINSONISM , 1969, Journal of the American Geriatrics Society.

[409]  J. Parkinson.  AN ESSAY ON THE SHAKING PALSY , 1969 .

[410]  J. Woodard.  CONCENTRIC HYALINE INCLUSION BODY FORMATION IN MENTAL DISEASE ANALYSIS OF TWENTY‐SEVEN CASES , 1962, Journal of neuropathology and experimental neurology.

[411]  L. Lipkin,et al.  DIFFUSE INTRACYTOPLASMIC GANGLIONIC INCLUSIONS (LEWY TYPE) ASSOCIATED WITH PROGRESSIVE DEMENTIA AND QUADRIPARESIS IN FLEXION , 1961, Journal of neuropathology and experimental neurology.

[412]  J. Greenfield,et al.  THE BRAIN-STEM LESIONS IN PARKINSONISM , 1953, Journal of neurology, neurosurgery, and psychiatry.

[413]  R. Klaue.  Parkinsonsche Krankheit (Paralysis agitans) und postencephalitischer Parkinsonismus , 1940, Archiv für Psychiatrie und Nervenkrankheiten.

[414]  E. Fünfgeld,et al.  Zur pathologischen Anatomie der Paralysis agitans , 1923 .

[415]  W. Gowers,et al.  A Manual of Diseases of the Nervous System , 1887, Edinburgh Medical Journal.

[416]  A. Tröster,et al.  Neuropsychology of dementia with Lewy bodies. , 2008, Handbook of clinical neurology.

[417]  U. Spampinato,et al.  A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia , 2004, European Journal of Nuclear Medicine.

[418]  C. H. Vanderwolf,et al.  Intracortical grafts of embryonic basal forebrain tissue restore low voltage fast activity in rats with basal forebrain lesions , 2004, Experimental Brain Research.

[419]  M. Yoshimura.  Cortical changes in the parkinsonian brain: a contribution to the delineation of “diffuse Lewy body disease” , 2004, Journal of Neurology.

[420]  R. Mayeux,et al.  Diffuse Lewy body disease , 2004, Acta Neuropathologica.

[421]  K. Brøsen,et al.  Clinical significance of the sparteine/debrisoquine oxidation polymorphism , 2004, European Journal of Clinical Pharmacology.

[422]  D. Mann,et al.  The topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease , 2004, Acta Neuropathologica.

[423]  R. Petersen,et al.  REM Sleep Behavior Disorder in Parkinson’s Disease, Dementia with Lewy Bodies, and Multiple System Atrophy , 2003 .

[424]  K. Rockwood,et al.  Coma with accidental single dose of an atypical neuroleptic in a patient with Lewy Body dementia. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[425]  E. Perry,et al.  Neurotransmitter Correlates of Neuropsychiatric Symptoms in Dementia with Lewy Bodies , 2003 .

[426]  James T Becker,et al.  Research evaluation and prospective diagnosis of dementia with Lewy bodies. , 2002, Archives of neurology.

[427]  G. Tarlow,et al.  Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. , 2002, The Journal of clinical psychiatry.

[428]  Joseph E Parisi,et al.  Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. , 2002, Archives of neurology.

[429]  E. Kosno-Kruszewska,et al.  Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study. , 2001, Folia neuropathologica.

[430]  P. Thompson,et al.  The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up. , 2001, The Journal of clinical psychiatry.

[431]  J. G. Evans,et al.  Oxford textbook of geriatric medicine , 2000 .

[432]  Martí-Massó Jf,et al.  [Dementia with Lewy bodies]. , 2000, Neurologia.

[433]  G. Ransmayr.  Dementia with Lewy bodies: prevalence, clinical spectrum and natural history. , 2000, Journal of neural transmission. Supplementum.

[434]  R. van Reekum,et al.  A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. , 2000, The Journal of neuropsychiatry and clinical neurosciences.

[435]  M. Tovée,et al.  Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. , 2000, Dementia and geriatric cognitive disorders.

[436]  J. Ghika.  [Genetics of parkinsonism]. , 2000, Revue medicale de la Suisse romande.

[437]  Wolters Ec.  Dopaminomimetic psychosis in Parkinson's disease patients: diagnosis and treatment. , 1999 .

[438]  M. L. Schmidt,et al.  Pathobiology of the Lewy body. , 1999, Advances in neurology.

[439]  R A Crowther,et al.  Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. , 1998, Neuroscience letters.

[440]  A. Blokland,et al.  Preclinical Pharmacology of Metrifonate: A Promise for Alzheimer Therapy , 1997 .

[441]  T. Robbins,et al.  Central cholinergic systems and cognition. , 1997, Annual review of psychology.

[442]  E. Perry,et al.  Lewy body dementia--clinical, pathological and neurochemical interconnections. , 1997, Journal of neural transmission. Supplementum.

[443]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.

[444]  D. Collerton,et al.  Dementia with Lewy Bodies: Lewy body dementia in clinical practice , 1996 .

[445]  E. Perry,et al.  Dementia with Lewy Bodies: Altered consciousness and transmitter signalling in Lewy body dementia , 1996 .

[446]  R. Mayer,et al.  Dementia with Lewy Bodies: Pathological significance of Lewy bodies in dementia , 1996 .

[447]  L. Thal,et al.  Extrapyramidal Motor Signs in Clinically Diagnosed Alzheimer Disease , 1996, Alzheimer disease and associated disorders.

[448]  E. Perry,et al.  Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias. , 1996, Journal of neural transmission. Supplementum.

[449]  E. Marshall,et al.  Dementia with Lewy Bodies: Neurochemical correlates of pathological and iatrogenic extrapyramidal symptoms , 1996 .

[450]  R. Armstrong,et al.  Alzheimer's disease and the eye , 1996, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[451]  D. Salmon,et al.  Dementia with Lewy Bodies: Neuropsychological aspects of Lewy body dementia , 1996 .

[452]  M. Memo,et al.  Dementia with Lewy Bodies: Cholinergic therapy and Lewy body dementia , 1996 .

[453]  R. McShane,et al.  Dementia with Lewy Bodies: Hallucinations, cortical Lewy body pathology, cognitive function and neuroleptic use in dementia , 1996 .

[454]  I. McKeith,et al.  Dementia with Lewy Bodies: Noncognitive symptoms in Lewy body dementia , 1996 .

[455]  P. Ince,et al.  A quantitative comparison of plaque types in Alzheimer’s disease and senile dementia of the Lewy body type , 1996, Acta Neuropathologica.

[456]  P. Thompson,et al.  Dopamine metabolism in postmortem caudate-nucleus in neurodegenerative disorders , 1994 .

[457]  E. Perry,et al.  Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia: Similarity to Parkinson's and Distinction from Alzheimer Disease , 1993, Alzheimer disease and associated disorders.

[458]  B J Baars,et al.  How does a serial, integrated and very limited stream of consciousness emerge from a nervous system that is mostly unconscious, distributed, parallel and of enormous capacity? , 1993, Ciba Foundation symposium.

[459]  S. Kuzuhara,et al.  Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly. , 1993, Advances in neurology.

[460]  I. McKeith,et al.  A comparative study of attentional deficits in senile dementias of Alzheimer and lewy body types , 1992 .

[461]  E. Perry,et al.  Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[462]  M. Mahowald,et al.  POLYSOMNOGRAPHIC, NEUROLOGIC, PSYCHIATRIC, AND CLINICAL OUTCOME REPORT ON 70 CONSECUTIVE CASES WITH REM SLEEP BEHAVIOR DISORDER (RBD) : SUSTAINED CLON AZEPAM EFFICAY IN 89.5% OF 57 TREATED PATIENTS , 1990 .

[463]  J. Hobson.  The Dreaming Brain , 1988 .

[464]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[465]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[466]  K. Kosaka,et al.  [A cliniconeurophathological study of the "Lewy body disease"]. , 1980, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica.

[467]  P. Osterrieth.  Le test de copie d'une figure complexe , 1944 .

[468]  F. Lewy.  Die Lehre vom Tonus und der Bewegung : Zugleich systematische Untersuchungen zur Klinik, Physiologie, Pathologie und Pathogenese der paralysis Agitans , 1923 .

[469]  F. Lewy.  Paralysis agitans. I. Pathologische Anatomie , 1912 .